Background Liver injury is a major health problem that challenges not only healthcare professionals but also the pharmaceutical industry and drug regulatory agencies. Continuous exposure to certain chemotherapeutic agents, drugs, environmental toxins, viral infections and bacterial invasion within the body can trigger liver injury and eventually lead to various liver diseases.
INTRODUCTION
The exposure of liver to injury is much higher than any other organ because of its central role in metabolism as well as its ability to concentrate and biotransform xenobiotics (Wang and Chaudry, 1996). In metabolism, the blood that reaches the liver through the portal circulation contains endotoxins, metabolic waste products, absorbed chemicals and other cell debris which represent a high risk of liver toxicity (Koporec et al., 1995). On the other hand, the fragile parenchymal cells with the easily disrupted glisson's capsule and the large size of the liver make this organ more susceptible to injury (Clancy et al., 2001) Paracetamol (PCM) is an over the counter (OTC) drug that is commonly used for its analgesic and antipyretic properties. However, PCM overdose is the most frequent cause of severe liver failure in the world and has a mortality rate of 90% (Zyoud et al., 2010). Nacetyl-p-benzoquinonimine (NAPQI) is the toxic metabolite of PCM overdose which causes depletion of the cellular glutathione content (Kedderis, 1990). Unconjugated NAPQI binds to cellular macromolecules leading to oxidative stress, cellular necrosis and finally cell death (Somani et al., 2000) .
Under this pathological condition, an extensive conversion of Xanthine dehydrogenase (XDH) to xanthine oxidase (XO) takes place (Haidari et al., 2009). XO uses molecular oxygen as an electron acceptor and leads to the formation of superoxide anion (O 2 -) and hydrogen peroxide (H 2 O 2 ) in parallel with uric acid production. Therefore, XO can act as a source of reactive oxygen species (ROS) and induce damage to biological macromolecules (Rackova et al., 2007) . Based on these facts, the inhibition of XO activity may decrease ROS production and result in anti-oxidative effects. Allopurinol is the sole xanthine oxidoreductase (XOR) inhibitor under clinical application (Fels and Sundy, 2008). In this investigation, the antioxidant effect of allopurinol was tested against NAC in PCMinduced liver injury in rats.
MATERIALS and METHODS

Animals
Adult male albino rats weighing (180 ± 10 g) were used in this study. Animals were purchased from Nile Company for Pharmaceuticals and Chemical Industries, El Ameria Area, Egypt. The rats were kept under standard conditions of temperature (25°C ± 0.5) and relative humidity (55  1) with 12-light/12-dark cycle for one week for adaptation before being subjected to laboratory experiments and were allowed free access to standard forage and drinking water ad libitum. Experimental protocol was designed according to the regulation of ethical committee Faculty of Pharmacy Beni-Sueif University.
Drugs and chemicals
Drugs: N-acetyl cysteine was provided as a kind gift from SEDICO Company (Egypt) in a form of authentic powder, whereas allopurinol and paracetamol (acetaminophen) were obtained as a kind gift from GlaxoSmithKline Company in a form of authentic powder. Chemicals and kits: alanine aminotransferase (ALT) and aspartate aminotransferase (AST) kits were purchased from (Spinreact Company, Spain). Glutathione powder (GSH ),1,1-3,3-tetramethoxypropane, 5,5`-Dithiobis-(2-nitrobenzoic acid; DTNB), horseradish peroxidase (1067 U/mg solid), O-dianisidine hydrochloride, O-phosphoric acid, N-(1-Naphthyl), ethylenediamine dihydrochloride (NEDD), sulfanilamide 2% (w/v), thiobarbituric acid and trichloroacetic acid (TCA) were purchased from (Sigma-Aldrich Company, MO, USA). Vanadium Chloride (VCl 3 ) was obtained from (Acros Company, Belgium). All other chemicals are of analytical grade.
Induction of liver injury in rats
After 13 consecutive days of pre-treatment, animals were fasted for 18 hours then received the last protected dose at day 14. After 2 hours, a single oral dose of paracetamol (750 mg/kg) was administered according to the method described by Plaa and Hewitt, (1982) and Dash et al. (2007) . Twenty four hours after PCM administration, animals were anaesthetized by thiopental sodium (75 mg/kg, intra-peritoneal) and blood samples were collected from retro-orbital plexus using heparinized micro-capillary tubes. After that, rats were sacrificed by cervical dislocation to separate liver samples (Kiran et al., 2012).
Experimental design
Rats were randomly assigned to four groups, each of 6 animals. The first group was kept as normal control group. The second group (hepatotoxicity control group) received a single dose of paracetamol (750 mg 
Assessment of liver injury
Preparation of tissue homogenate
To prepare liver homogenate 20%, a portion of the median or left lobes was homogenized with 5 volumes of isotonic ice-cooled normal saline using a homogenizer for the estimation of hepatic MDA content, hepatic GSH content and CAT activity as oxidative biomarkers and nitrate/nitrite production as inflammatory biomarker.
Another portion was homogenized with 60 volumes of ice-cooled hexadecyl trimethylammonium bromide (1%) solution in normal saline and centrifuged at 4000 xg for 15 minutes at 4 °C in a cooling centrifuge. The supernatant was used for the estimation of hepatic MPO activity as inflammatory biomarker.
Histopathological study
Samples were fixed in 10% formal saline for histological examination. Samples were embedded in paraffin, and sections were stained with haematoxylin and eosin for histological evaluation of hepatic damage by light microscopy.
Treatment of blood sample
After collecting blood samples in centrifuge tubes, the tubes were allowed to coagulate at room temperature, then placed in water bath at 37 ºC for 10 minutes. Centrifugation at 1000 xg for 20 minutes was performed. The clear serum was separated and used for determination of ALT and AST.
Quantitative determination of alanine aminotransferase (ALT) and aspartate aminotransferase (AST)
Serum ALT and AST activities reflect the release of these enzymes from injured liver cells and their serum levels were assayed quantitatively according to the manufacturing procedure (Young, 1990) . The change in absorbance (ΔA/minute) was measured at 340 nm over 3 minutes spectrophotometrically.
Determination of myeloperoxidase (MPO) activity:
Myeloperoxidase activity served as quantitative index of neutrophil infiltration and inflammation in several tissues (Bradley et al., 1982). Liver MPO activity was measured in liver homogenate according to the manufacturing procedure Harada et al., 1999. The change in absorbance (ΔA/minute) was measured at 460 nm over 3 minutes spectrophotometrically.
Determination of total nitrate/nitrite (NOx) ratio:
The levels of NO and iNOS activities in liver tissues were measured colorimetrically using spectrophotometer at 540 nm according to the method described by Miranda et al.
(2001).
Determination of Lipid peroxidation:
Lipid peroxidation products were estimated by the determination of the level of thiobarbituric acid reactive species (TBARS) that were measured as malondialdehyde (MDA) in liver homogenates according to the method described by Uchiyama and Mihara (1978). MDA was measured colorimetrically using spectrophotometer sat two wavelengths, namely 520 and 535 nm, to exclude interfering substances. The difference in absorbance at both wavelengths was used to calculate the content of TBARS in the sample.
Determination of reduced glutathione:
Glutathione was measured in liver homogenate according to the method described by Sedlak and Lindsay (1968). The principle of the method depends on the reduction of 5,5`-Dithiobis-(2-nitrobenzoic acid; DTNB) by the sulfhydryl group of GSH. The formed product was measured colorimetrically at 412 nm. Results were expressed as µmol/g tissue.
Determination of catalase (CAT) activity:
Catalase (CAT) activity was measured in hepatic tissues according to Clairborne (1985) . The principle of this method depends on the decrease in catalase activity due to the decomposition of hydrogen peroxide at 240 nm. Enzyme activity was expressed as U/g tissue.
Statistical analysis:
All data are expressed as mean ± standard error (S.E.) of 6 rats per experimental group. Statistical analysis was performed using one-way ANOVA followed by Student-Newmankeuls multiple comparisons test by the aid of Graph bad prism and Graph pad instant computer software, San Diego, USA. P < 0.05 was used as a criteria for significance between data.
RESULTS:
Histopathological study
On histological examination of rat liver sections from the normal group, the histological features were typically of normal architecture (Fig, 1A) .
Liver sections obtained from PCM group showed loss of normal hepatic architecture and congested central vein. Massive inflammatory reactions and activated Von Kupffer cells were also observed. Hepatocytes showing cellular degeneration and Centrilobular necrosis (Fig, 1B) .
Treatment with NAC (300 mg/kg) or allopurinol (50 mg/kg) attenuated the extent and severity of the histological signs of tissue damage in liver tissues (Fig; 1C, 1D 
Serum ALT and AST activities
Serum ALT activity was significantly increased in PCM group to about 260 % as compared with the normal group; while treatment with NAC or allopurinol significantly decreased ALT to reach about 56 % or 65 % , respectively, as compared to PCM group (Fig,  2A ). Alternatively, Serum AST level was significantly increased in PCM group to about 324 % as compared with the normal group; while NAC or allopurinol significantly decreased ALT to reach about 43 % and 61 %, respectively, as compared to PCM group (Fig, 2B) .
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Fig (2): Effect of oral treatment with allopurinol for 14 consecutive days on serum ALT (A) and AST (B) activities as compared to NAC intake on liver enzyme activities against PCMinduced liver injury in rats.
* significantly different from the respective normal control values at p < 0.05. @ significantly different from the respective PCM control value at p < 0.05.
Hepatic MPO activity
The MPO activity of hepatic tissue was significantly increased in PCM group to about 1005 % as compared to the normal control group; while treatment with NAC or allopurinol significantly decreased hepatic MPO activity to reach about 15% and 14 %, respectively, as compared to PCM group (Fig, 3A) .
Total nitrate/nitrite (NOx) ratio
Oral administration of PCM significantly increased hepatic NOx production as compared with normal control group to about 176 %. On the other hand, treatment with NAC or allopurinol significantly decreased hepatic NOx production to reach about 71 % and 78 %, respectively, as compared to PCM group (Fig, 3B) (A) (B) Fig (3) : Effect of oral treatment with allopurinol for 14 consecutive days on hepatic MPO activity (A) and NOx production (B) as compared to NAC intake against PCM-induced liver injury in rats.
* significantly different from the respective sham control values at p < 0.05. @ significantly different from the respective toxicity control value at p < 0.05.
Hepatic MDA content
Hepatic MDA content was significantly increased in PCM group to about 575 % as compared to normal control group; while a significant decrease in hepatic MDA content occurred after treatment of rats with NAC or allopurinol to reach about 51 % and 46 %, respectively, as compared to PCM group (Fig, 4A) .
Hepatic content of reduced glutathione
Compared to normal control group, hepatic GSH content was significantly decreased in PCM group to about 34 %. After treatment with NAC or allopurinol a significant increase in hepatic GSH content was occurred to reach about 179 % and 178 %, respectively, as compared to PCM group (Fig, 4B) . 
Hepatic catalase (CAT) activity
Administration of PCM significantly decreased hepatic CAT activity to about 4,4 % as compared to normal control group; meanwhile treatment with NAC or allopurinol significantly increased hepatic CAT activity to reach about 1150 % and 950 %, respectively, as compared to PCM group (Fig, 5) 
Fig (5):
Effect of oral treatment with allopurinol for 14 consecutive days on hepatic CAT activity as compared to NAC intake against PCM-induced liver injury in rats.
* Significantly different from sham control value at p < 0.05 @ Significantly different from ulcer control value at P < 0.05
DISCUSSION:
Current investigation showed that single oral dose administration of PCM (750 mg/kg) caused acute liver damage to rats as evidenced by significant increases in serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities. In addition, there were significant increases in hepatic malondialdehyde (MDA) content, myeloperoxidase (MPO) activity and total nitrate/nitrite (NOx) production. On the other hand, significant decreases in hepatic glutathione (GSH) content and catalase (CAT) activity were observed. Histopathological examination further supported hepatotoxicity induced by PCM over dose. Approximately 5 % to 9 % of the given dose of PCM undergoes oxidative conversion by way of the cytochrome P 450 enzymes to the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI; Kaplowitz, 2004). CYP 2 E 1 is the major source of NAPQI formation which is a highly reactive electron species that can act as an electrophile or an oxidant radical. Normally, it is rapidly metabolized by conjugation with intracellular GSH forming a nontoxic PCM-GSH conjugate which is finally excreted as mercapturic acid and cysteine conjugates (James et al., 2003) .
At toxic doses, the sulfation and glucuronidation routes become saturated and hence, higher percentages of PCM molecules are oxidized to highly reactive NAPQI (Eesha et al., 2011). NAPQI can covalently bind to macromolecules of cellular membrane and increase the lipid peroxidation (LPO) resulting in tissue damage. In addition, NAPQI can also alkylate and oxidise intracellular GSH, which results in depletion of liver GSH pool. GSH depletion further contributes to cellular oxidative stress, DNA damage and subsequently leads to necrotic cell death (Hinson et al., 2004) . , 2014) . It has the ability to restore the hepatocellular GSH content. It can enter cells more easily due to its small size and it is converted enzymatically to cysteine which is a precursor for GSH biosynthesis (Finamor et al., 2014) . Therefore, NAC can eliminate electrophonic intermediates and free radicals through conjugation and reduction reactions (Kalantari and Salehi, 2001).
The antioxidant activity of NAC was evidenced also by the significant decrease of LPO which was evidenced in the present investigation where NAC was able to decrease MDA content. The antioxidant activity of NAC was further confirmed by the significant increases in CAT activity. These results are similar to the results of Galicia-Moreno et al. Based on these facts, the inhibition of XOR activity may decrease ROS production and result in anti-oxidative effects (Fels and Sundy, 2008).
Allopurinol competitively inhibits the action of XOR and effectively protects against free radical production, releasing of inflammatory mediators and against tissue damage (Viña et al., 2000) . Therefore, the antioxidant properties of allopurinol are referred to its inhibition of XO which can lower the ROS load of the body, thereby making endogenous reducing equivalents available for other detoxification reactions (Lin et al., 2000) . In addition, the present work showed that allopurinol has anti-inflammatory activity as evidenced by significant decrease in hepatic MPO activity and NOx production in PCM model. These results confirm the work of other investigators who reported similar decrease in hepatic MPO activity. Ansari et al. (2013) reported that allopurinol decreased MPO activity and exerted a neuroprotective effect against cerebral ischemic reperfusion injury in diabetic rats. Further support for this idea was provided by Makay et al. (2009) who reported similar decrease in NO X production during studying the mitigating role of allopurinol on oxidative stress in experimental hyperthyroidism. In addition, Alorainy (2008) reported similar decrease in NO X level by allopurinol in rat model of rheumatoid arthritis.
CONCLUSION
In conclusion we suggest that allopurinol may be a promising agent for protection against liver injury compared with NAC. Further sufficient preclinical and clinical studies should be conducted to clarify this fact. 
